methamphetamine has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byard, RW; Kenneally, M; Lewis, D; van den Heuvel, C | 1 |
| Bai, CX; Chen, J; Hong, QY; Wang, YH | 1 |
2 other study(ies) available for methamphetamine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Increasing age and methamphetamine use.
Topics: Adolescent; Adult; Age Distribution; Amphetamine-Related Disorders; Australia; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Myocardial Ischemia; Pulmonary Disease, Chronic Obstructive; Sex Distribution; Young Adult | 2021 |
Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Interleukin-1; Interleukin-6; Leukocyte Count; Male; Methamphetamine; Neutrophils; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2003 |